Cargando…
Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new?
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276505/ https://www.ncbi.nlm.nih.gov/pubmed/32512515 http://dx.doi.org/10.1016/j.ebiom.2020.102812 |
_version_ | 1783542964216135680 |
---|---|
author | Chehrazi-Raffle, Alexander Pal, Sumanta Kumar |
author_facet | Chehrazi-Raffle, Alexander Pal, Sumanta Kumar |
author_sort | Chehrazi-Raffle, Alexander |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7276505 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-72765052020-06-10 Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new? Chehrazi-Raffle, Alexander Pal, Sumanta Kumar EBioMedicine Commentary Elsevier 2020-06-05 /pmc/articles/PMC7276505/ /pubmed/32512515 http://dx.doi.org/10.1016/j.ebiom.2020.102812 Text en © 2020 Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Commentary Chehrazi-Raffle, Alexander Pal, Sumanta Kumar Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new? |
title | Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new? |
title_full | Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new? |
title_fullStr | Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new? |
title_full_unstemmed | Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new? |
title_short | Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new? |
title_sort | vorolanib and everolimus: lenvatinib and everolimus part deux, or something new? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276505/ https://www.ncbi.nlm.nih.gov/pubmed/32512515 http://dx.doi.org/10.1016/j.ebiom.2020.102812 |
work_keys_str_mv | AT chehrazirafflealexander vorolanibandeverolimuslenvatinibandeverolimuspartdeuxorsomethingnew AT palsumantakumar vorolanibandeverolimuslenvatinibandeverolimuspartdeuxorsomethingnew |